Related Experiment Video

Updated: Mar 10, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.6K

Forkhead Box A2 (FOXA2) Inhibits Invasion and Tumorigenesis in Glioma Cells

Bingqian Ding, Huimin Liang, Ming Gao

    Oncology Research
    |December 17, 2016
    PubMed

    Insights

    Forkhead box A2 (FOXA2) is downregulated in glioma. Restoring FOXA2 expression inhibits glioma cell proliferation, migration, invasion, and tumor growth, suggesting FOXA2 as a potential therapeutic target.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • The transcription factor forkhead box A2 (FOXA2) is implicated in tumorigenesis.
    • The specific role and expression patterns of FOXA2 in glioma remain largely uncharacterized.

    Purpose of the Study:

    • To investigate the expression profile of FOXA2 in human glioma.
    • To elucidate the functional role of FOXA2 in glioma cell behavior and tumorigenesis.

    Main Methods:

    • Analysis of FOXA2 expression in human glioma cell lines.
    • Functional assays assessing proliferation, migration, and invasion upon FOXA2 overexpression.
    • In vivo xenograft studies in nude mice to evaluate tumor growth.
    • Western blot analysis to determine the expression of key proteins like β-catenin, cyclin D1, and c-Myc.

    Main Results:

    • FOXA2 expression was significantly downregulated in human glioma cell lines.
    • Forced expression of FOXA2 suppressed glioma cell proliferation, migration, and invasion.
    • Overexpression of FOXA2 led to decreased expression of EMT-associated proteins.
    • In vivo studies demonstrated that FOXA2 attenuated glioma tumor growth.
    • Mechanistically, FOXA2 overexpression downregulated β-catenin, cyclin D1, and c-Myc.

    Conclusions:

    • FOXA2 plays a crucial role in suppressing glioma cell proliferation, invasion, and overall tumorigenesis.
    • FOXA2 functions by downregulating key oncogenic pathways involving β-catenin, cyclin D1, and c-Myc.
    • FOXA2 represents a promising therapeutic target for glioma treatment.

    More Related Videos

    A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs08:35

    A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs

    Published on: July 20, 2017

    13.7K
    Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion09:23

    Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

    Published on: October 20, 2016

    14.9K

    Related Concept Videos

    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    7.7K
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    10.0K
    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
    6.1K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    5.0K